Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism KDM3B agonists(lysine demethylase 3B agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization- |
Active Organization- |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
acute leukemia | Preclinical | - | - | 29 Nov 2018 |